NFKB1 and myocardial infarction: In the current study, we displayed the cardio-protection influence of Amlexanox, a GRK5 inhibitor, in an animal model of MI, particularly focusing on its inhibitory effect on GRK5 modulation of NF-κB-mediated inflammatory effects.